CVS Health Corp banner

CVS Health Corp
LSE:0HRS

Watchlist Manager
CVS Health Corp Logo
CVS Health Corp
LSE:0HRS
Watchlist
Price: 103.78 USD -0.76% Market Closed
Market Cap: $131.5B

Wall St Price Targets

0HRS Price Targets Summary
CVS Health Corp

Wall Street analysts forecast 0HRS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0HRS is 101.99 USD with a low forecast of 80.06 USD and a high forecast of 119.05 USD.

Lowest Forecast
Price Target
80.06 USD
23% Downside
Average Forecast
Price Target
101.99 USD
2% Downside
Highest Forecast
Price Target
119.05 USD
15% Upside
CVS Health Corp Competitors:
Price Targets
SRFM
Surf Air Mobility Inc
483% Upside

Revenue
Forecast

10% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
10% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

7% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

4% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
4% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 23%.

Pre-Tax Income
Forecast

-7% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
-7% / Year
Past Growth
97% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -7%. The projected CAGR for the next 3 years is 97%.

Net Income
Forecast

-5% / Year
Past Growth
90% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
-5% / Year
Past Growth
90% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 90%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0HRS's stock price target?
Price Target
101.99 USD

According to Wall Street analysts, the average 1-year price target for 0HRS is 101.99 USD with a low forecast of 80.06 USD and a high forecast of 119.05 USD.

What is the Revenue forecast for CVS Health Corp?
Projected CAGR
4%

Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for CVS Health Corp?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 5%.

What is the Operating Income forecast for CVS Health Corp?
Projected CAGR
23%

Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 23%.

What is the Pre-Tax Income forecast for CVS Health Corp?
Projected CAGR
97%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -7%. The projected CAGR for the next 3 years is 97%.

What is the Net Income forecast for CVS Health Corp?
Projected CAGR
90%

Over the last 14 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 90%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett